We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+151.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$601M
AUM Growth
+$166M
Cap. Flow
+$564M
Cap. Flow %
93.74%
Top 10 Hldgs %
55.84%
Holding
582
New
177
Increased
66
Reduced
116
Closed
191

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.9%
2 Healthcare 14.37%
3 Financials 8.14%
4 Industrials 2.53%
5 Technology 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
451
CALL
Ocular Therapeutix
OCUL
$2.03B
-32,900
Closed -$16K
PCG icon
452
CALL
PG&E
PCG
$37.5B
-787,500
Closed -$957K
PCG icon
453
PG&E
PCG
$37.5B
-210,695
Closed -$1.89M
PFF icon
454
PUT
iShares Preferred and Income Securities ETF
PFF
$13.2B
-200,000
Closed -$215K
PRDO icon
455
CALL
Perdoceo Education
PRDO
$1.97B
-72,000
Closed -$23K
PRDO icon
456
PUT
Perdoceo Education
PRDO
$1.97B
-28,000
Closed -$50K
PTON icon
457
Peloton Interactive
PTON
$2.42B
-40,277
Closed -$1.67M
QDEL icon
458
CALL
QuidelOrtho
QDEL
$943M
-900
Closed -$12K
QDEL icon
459
QuidelOrtho
QDEL
$943M
-10,324
Closed -$1.62M
QQQ icon
460
CALL
Invesco QQQ Trust
QQQ
$479B
-2,900
Closed -$54K
QURE icon
461
uniQure
QURE
$3.2B
-30,599
Closed -$1.45M
RRC icon
462
CALL
Range Resources
RRC
$9.41B
-20,000
Closed -$2K
RVPHW
463
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
-57,100
Closed -$5K
SJ icon
464
Scienjoy Holding
SJ
$34.8M
-261,893
Closed -$2.68M
SMH icon
465
CALL
VanEck Semiconductor ETF
SMH
$70.1B
-22,000
Closed -$45K
SMH icon
466
VanEck Semiconductor ETF
SMH
$70.1B
-18,032
Closed -$1.06M
SMH icon
467
PUT
VanEck Semiconductor ETF
SMH
$70.1B
-69,400
Closed -$643K
SNDL icon
468
CALL
Sundial Growers
SNDL
$303M
-2,240
Closed -$1K
SRPT icon
469
Sarepta Therapeutics
SRPT
$1.81B
-3,589
Closed -$351K
SRPT icon
470
PUT
Sarepta Therapeutics
SRPT
$1.81B
-20,500
Closed -$615K
TEVA icon
471
CALL
Teva Pharmaceuticals
TEVA
$42.1B
-336,500
Closed -$200K
TEVA icon
472
PUT
Teva Pharmaceuticals
TEVA
$42.1B
-1,426,300
Closed -$3.38M
TLT icon
473
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
-14,500
Closed -$23K
TLT icon
474
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
-2,100
Closed -$346K
TLT icon
475
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
-14,500
Closed -$45K

Similar funds

Cowen and Company's Q2 2020 Portfolio in Review

As of Q2 2020, Cowen and Company held 582 positions worth $601M, up 38% from $435M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cowen and Company deployed $564M of net new capital in Q2 2020, opening 177 new positions and adding to 66 existing holdings. Its largest new stake was Carnival Corporation Ltd: 1,476,800 shares worth $24.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M trimmed.

  • Cowen and Company's largest Q2 2020 buy was Carnival Corporation Ltd: 1,476,800 shares worth $24.2M.
  • Cowen and Company added most to Nikola Corporation Common Stock in Q2 2020, an estimated $23.3M increase.
  • Cowen and Company's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Cowen and Company fully exited Match Group in Q2 2020, selling an estimated $19.8M.
  • Cowen and Company's ten largest holdings make up 56% of its $601M portfolio in Q2 2020.
  • Cowen and Company opened 177 new positions and closed 191 in Q2 2020.
  • Cowen and Company's portfolio value rose 38% quarter-over-quarter to $601M.

Based on Cowen and Company's 13F filing for Q2 2020, filed 13 Aug 2020.